unknown
Stage
About
Biogenera develops targeted therapies for MYCN-positive tumors.
Explore Biogenera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Biogenera develops targeted therapies for MYCN-positive tumors.
Funding rounds, investor list, and risk signals — unlock with a subscription.